Company Filing History:
4 out of 159 
4 out of 100 
1 out of 1 Years Active: 2021-2025
Title: The Innovative Journey of Zhuoxiao Cao
Introduction
Zhuoxiao Cao, an accomplished inventor based in Shanghai, China, has made significant contributions to the field of biotechnology with his innovative work. With a remarkable portfolio of four patents, he has focused primarily on advancements in antibody technologies that hold promising implications for medical applications.
Latest Patents
Cao's latest patents include groundbreaking developments such as the LAG-3 antibody and its antigen-binding fragment, along with their pharmaceutical applications. This invention provides not only the LAG-3 antibody but also a chimeric and humanized antibody based on its framework. It includes a pharmaceutical composition that contains the LAG-3 antibody and its binding fragment. This composition is particularly notable for its application as an antineoplastic drug aimed at treating diseases linked to immune cell dysfunction.
Another key patent is the TIGIT antibody, which similarly encompasses an antigen-binding fragment and outlines its medical use. This patent details the development of murine, chimeric, and humanized antibodies comprising the CDR region of the TIGIT antibody, along with a pharmaceutical composition for medical applications. The innovations here focus on the potential of humanized TIGIT antibodies in preparing treatments for diseases associated with the TIGIT pathway.
Career Highlights
Zhuoxiao Cao has had a distinguished career working with renowned companies in the pharmaceutical sector. Notably, he has had roles at Jiangsu Hengrui Medicine Company Ltd. and Shanghai Hengrui Pharmaceutical Co., Ltd., where he significantly contributed to research and development initiatives in antibody therapies.
Collaborations
Throughout his career, Cao has collaborated with esteemed colleagues such as Yayuan Fu and Weikang Tao. Their joint efforts have likely contributed to the innovative spirit and scientific rigor that characterize his work in developing novel therapeutic solutions.
Conclusion
Zhuoxiao Cao has firmly established himself as an influential inventor within the biotechnology landscape. His recent patents, particularly in the field of LAG-3 and TIGIT antibodies, illustrate his dedication to advancing therapeutic options for various diseases. As he continues his work, the impact of his innovations is poised to make a significant difference in medical science.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.